How the combination treatment challenge impacts patients and how we are working together to solve it
How the combination treatment challenge impacts patients
Access to medicines attracts a great deal of interest from patients, clinicians, and the public and there have been significant advances in drug development in recent years which looks set to continue.
Many new treatments can provide improved outcomes for patients, extending and increasing their quality of life. However, in some cases, funding new treatments can present a challenge to health systems around the world as budgets are finite. Therefore extensive consideration of the clinical and cost-effectiveness of treatments must be made, to justify their value for money and their value to the health system.
The combination treatment issue
Combination treatments combine two or more individual treatments, and have the potential to deliver significant clinical benefits to people with complex diseases such as cancer, HIV, rheumatoid arthritis, and Hepatitis C.
As understanding of disease increases, combination treatments are becoming increasingly common and critical to improving patient outcomes.